These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


94 related items for PubMed ID: 225000

  • 1. Elevated prolactin levels in bronchogenic carcinoma.
    Davis S, Proper S, May PB, Ertel NH.
    Cancer; 1979 Aug; 44(2):676-9. PubMed ID: 225000
    [Abstract] [Full Text] [Related]

  • 2. Circulating hormones in lung cancer.
    Behera D, Malik SK, Sharma BR, Dash RJ.
    Indian J Med Res; 1984 May; 79():636-40. PubMed ID: 6096269
    [No Abstract] [Full Text] [Related]

  • 3. Infrequent elevation of plasma ACTH in patients with bronchogenic carcinoma.
    Davis S, May PB.
    Am J Med Sci; 1982 May; 283(1):2-7. PubMed ID: 6275702
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tissue polypeptide antigen in bronchogenic carcinoma.
    Zatloukal P, Glagolicová A, Linhart M, Sebes A, Hencl P, Mĕricka O.
    Neoplasma; 1993 May; 40(5):301-3. PubMed ID: 8272159
    [Abstract] [Full Text] [Related]

  • 7. Increased serum calcitonin levels in bronchogenic cancer.
    Silva OL, Becker KL, Primack A, Doppman JL, Snider RH.
    Chest; 1976 Apr; 69(4):495-9. PubMed ID: 177250
    [Abstract] [Full Text] [Related]

  • 8. Circulating blood RNA in lung cancer.
    Behera D, Mallik SK, Dani HM, Gumbhir K.
    J Assoc Physicians India; 1986 Aug; 34(8):579-80. PubMed ID: 2432053
    [No Abstract] [Full Text] [Related]

  • 9. Dissociation of thyrotropin and prolactin responsiveness to thyrotropin releasing hormone stimulation in L-dopa treated parkinsonian patients.
    Rabey JM, Vardi Y, Ravid R, Ayalon D.
    Horm Res; 1981 Aug; 15(2):78-87. PubMed ID: 6799381
    [Abstract] [Full Text] [Related]

  • 10. Blood coagulation and fibrinolysis in patients with carcinoma of the lung.
    Brugarolas A, Elias EG, Takita H, Mink IB, Mittelman A, Ambrus JL.
    J Med; 1973 Aug; 4(2):96-105. PubMed ID: 4127138
    [No Abstract] [Full Text] [Related]

  • 11. Adrenocorticotropin, calcitonin, and antidiuretic hormone as tumor markers in patients with bronchogenic carcinoma of various histological types.
    Winkelmann W, Deuss U, Allolio B, Hummerich W, Kaulen D, Brosch H, Guyot A, Arnold C.
    Klin Wochenschr; 1984 Nov 02; 62(21):1018-24. PubMed ID: 6096627
    [Abstract] [Full Text] [Related]

  • 12. Suppression by thyrotropin-releasing hormone (TRH) of human growth hormone release induced by L-dopa.
    Maeda K, Kato Y, Chihara K, Ogo S, Iwasaki Y.
    J Clin Endocrinol Metab; 1975 Aug 02; 41(2):408-11. PubMed ID: 239963
    [Abstract] [Full Text] [Related]

  • 13. Serum vitamin 'A' in bronchogenic carcinoma.
    Jain NC, Gupta AP, Saksena HC.
    J Assoc Physicians India; 1984 Jun 02; 32(6):485-6. PubMed ID: 6511722
    [No Abstract] [Full Text] [Related]

  • 14. On the presence of immunoreactive growth hormone in a bronchogenic carcinoma.
    Cameron DP, Burger HG, DeKretzer DM, Catt KJ, Best JB.
    Australas Ann Med; 1969 May 02; 18(2):143-6. PubMed ID: 4893571
    [No Abstract] [Full Text] [Related]

  • 15. Serum calcitonin after pentagastrin stimulation in patients with bronchogenic and breast cancer compared to that in patients with medullary thyroid carcinoma.
    Samaan NA, Castillo S, Schultz PN, Khalil KG, Johnston DA.
    J Clin Endocrinol Metab; 1980 Aug 02; 51(2):237-41. PubMed ID: 6249833
    [Abstract] [Full Text] [Related]

  • 16. Calcitonin as a marker for bronchogenic cancer: a prospective study.
    Silva OL, Broder LE, Doppman JL, Snider RH, Moore CF, Cohen MH, Becker KL.
    Cancer; 1979 Aug 02; 44(2):680-4. PubMed ID: 476577
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sedimentation rate, leucocytes, platelet count and haemoglobin in bronchial carcinoma: an epidemiological study.
    Gislason T, Nõu E.
    Eur J Respir Dis; 1985 Feb 02; 66(2):141-6. PubMed ID: 2982631
    [Abstract] [Full Text] [Related]

  • 19. [Plasma prolactin and GH response after thyrotropin-releasing hormone (TRH), L-DOPA and sulpiride in patients with senile dementia of Alzheimer type].
    Fujita M, Toyoda K, Motomura N, Kuroda K, Shimizu T.
    Rinsho Shinkeigaku; 1985 Jul 02; 25(7):767-75. PubMed ID: 3935351
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.